Exp Mol Med.
1999 Jun;31(2):101-107.
Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin
- Affiliations
-
- 1Mogam Biotechnology Research Institute, Kyonggido, Korea.
Abstract
- Escherichia coli heat-labile enterotoxin (LT) is composed of catalytic A and
non-catalytic homo-pentameric B subunits and causes diarrheal disease in human
and animals. In order to produce a nontoxic LT for vaccine and adjuvant
development, two novel derivatives of LT were constructed by a site-directed
mutagenesis of A subunit; Ser63 to Tyr63 in LTS63Y and Glu110, Glu112 were
deleted in LT delta 110/112. The purified mutant LTs (mLTs) showed a similar
molecular structural complex as AB5 to that of wild LT. In contrast to wild-type
LT, mLTs failed to induce either elongation activity, ADP-ribosyltransferase
activity, cAMP synthesis in CHO cells or fluid accumulation in mouse small
intestine in vivo. Mice immunized with mLTs either intragastrically or
intranasally elicited high titers of LT-specific serum and mucosal antibodies
comparable to those induced by wild-type LT. These results indicate that
substitution of Ser63 to Tyr63 or deletion of Glu110 and Glu112 eliminate the
toxicity of LT without a change of AB5 conformation, and both mutants are
immunogenic to LT itself. Therefore, both mLTs may be used to develop novel
anti-diarrheal vaccines against enterotoxigenic E. coli.